Anna Djos
-
Analysis of ALK, MYCN, and the ALK ligand ALKAL2 (FAM150B/AUG alpha) in neuroblastoma patient samples with chromosome arm 2p
rearrangements
Niloufar Javanmardi, Susanne Fransson, Anna Djos, Ganesh Umapathy, Malin Östensson, J. Milosevic, Marcus Borenäs, Bengt Hallberg, P. Kogner, Tommy Martinsson, Ruth H. Palmer
Genes Chromosomes & Cancer - 2020-01-01 -
Low Frequency ALK Hotspots Mutations In Neuroblastoma Tumours Detected By Ultra-deep Sequencing: Implications For ALK Inhibitor
Treatment
Niloufar Javanmardi, Susanne Fransson, Anna Djos, Rose-Marie Sjöberg, Staffan Nilsson, Katarina Truvé, P. Kogner, Tommy Martinsson
Scientific Reports - 2019-01-01 -
MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted
neuroblastomas.
Ganesh Umapathy, Jikui Guan, Dan Gustafsson, Niloufar Javanmardi, Diana Lizeth Cervantes-Madrid, Anna Djos, Tommy Martinsson, Ruth H. Palmer, Bengt Hallberg
Science signaling - 2017-01-01 -
Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic
tumors
A. P. Berbegall, E. Villamon, M. Piqueras, I. Tadeo, Anna Djos, P. F. Ambros, Tommy Martinsson, I. M. Ambros, A. Canete, V. Castel, S. Navarro, R. Noguera
Oncogene - 2016-01-01 -
Estimation of copy number aberrations: Comparison of exome sequencing data with SNP microarrays identifies homozygous deletions of 19q13.2 and iin
neuroblastoma
Susanne Fransson, Malin Östensson, Anna Djos, Niloufar Javanmardi, P. Kogner, Tommy Martinsson
International Journal of Oncology - 2016-01-01 -
Intragenic anaplastic lymphoma kinase (ALK) rearrangements: Translocations as a novel mechanism of ALK activation in neuroblastoma
tumors.
Susanne Fransson, Magnus Hansson, Kristina Ruuth, Anna Djos, Ana Berbegall, Niloufar Javanmardi, Jonas Abrahamsson, Ruth H. Palmer, Rosa Noguera, Bengt Hallberg, Per Kogner, Tommy Martinsson
Genes, chromosomes & cancer - 2015-01-01 -
Emergence of New ALK Mutations at Relapse of
Neuroblastoma
G. Schleiermacher, Niloufar Javanmardi, V. Bernard, Q. Leroy, J. Cappo, T. R. Frio, G. Pierron, E. Lapouble, V. Combaret, F. Speleman, B. de Wilde, Anna Djos, I. Ora, F. Hedborg, C. Trager, B. M. Holmqvist, Jonas Abrahamsson, M. Peuchmaur, J. Michon, I. Janoueix-Lerosey, P. Kogner, O. Delattre, Tommy Martinsson
Journal of Clinical Oncology - 2014-01-01 -
Aneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2
gene.
Anna Djos, Susanne Fransson, Per Kogner, Tommy Martinsson
BMC medical genetics - 2013-01-01 -
Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q
Deletion
E. Villamon, A. P. Berbegall, M. Piqueras, I. Tadeo, V. Castel, Anna Djos, Tommy Martinsson, S. Navarro, R. Noguera
PLoS ONE - 2013-01-01 -
Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma
cells
C. Schönherr, K. Ruuth, S. Kamaraj, C. L. Wang, H. L. Yang, V. Combaret, Anna Djos, Tommy Martinsson, J. G. Christensen, R. H. Palmer, B. Hallberg
Oncogene - 2012-01-01 -
The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in
neuroblastoma.
Anna Djos, Tommy Martinsson, Per Kogner, Helena Carén
Molecular cancer - 2012-01-01 -
Identification of epigenetically regulated genes that predict patient outcome in
neuroblastoma
Helena Carén, Anna Djos, Maria Nethander, Rose-Marie Sjöberg, Per Kogner, Camilla Enström, Staffan Nilsson, Tommy Martinsson
BMC Cancer - 2011-01-01